Chang-Yeu Liu

Title: Chang-Yeu Liu: Innovator in Immunostimulatory Protein Technology

Introduction

Chang-Yeu Liu is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of immunology through his innovative research and patent developments. His work focuses on the applications of starch binding protein (SBP)-tagged immunostimulatory proteins, which have potential implications in treating viral and protozoan infections.

Latest Patents

Chang-Yeu Liu holds a patent for the "Uses of starch binding protein (SBP)-tagged immunostimulatory protein." This invention outlines a method for preventing or treating virus and protozoa infections in subjects. The method involves orally administering a composition that includes a complex of SBP-tagged immunostimulatory protein and a SBP-binding matrix. Additionally, the patent describes methods for inducing interferon-gamma production and improving feed intake, growth rate, or feed conversion ratios in subjects.

Career Highlights

Chang-Yeu Liu is associated with Simpson Biotech Co., Ltd., where he continues to advance his research in immunostimulatory proteins. His work has garnered attention for its potential applications in both human and animal health. Liu's innovative approach combines biochemistry and immunology, leading to breakthroughs in treatment methodologies.

Collaborations

Chang-Yeu Liu collaborates with Chia-Chin Sheu, contributing to the development of new technologies and methodologies in the field of immunology. Their partnership enhances the research capabilities at Simpson Biotech Co., Ltd.

Conclusion

Chang-Yeu Liu is a prominent inventor whose work in immunostimulatory proteins has the potential to revolutionize treatment options for viral and protozoan infections. His contributions to the field are significant and continue to inspire further research and innovation.